A total of 145,347 samples (4,322 cases) were received for the passive surveillance of melioidosis in the Serology Laboratory of Veterinary Research Institute (VRI) from the year 2012 to 2016. From the samples received, 0.63% were positive and 99.37% were negative. The objective of this study is to determine the seropositive rate and distribution of melioidosis in livestockbased on cases received which comprise of sheep (37.24%, n=54,130), goat (54.01%, n=78,500), cattle (8.12%, n=11,804) andbuffalo (0.63%, n=913) within the period of 5 years. A geographical mapping of seropositive cases was designed using thedata from the passive surveillance and the results were visualized in a geographical mapping which provides a clear visual description on the distribution of the diseases. By 2016, positive cases were found to be concentrated in the states on the east coast of Peninsular Malaysia and Sabah. To sum up, the percentage of seropositive cases of melioidosis in 5 years has increased from 1.79% in 2012 to 12.17% in 2015 and decreased to 1.04% in 2016. From the findings, this study can provide the dataneeded as the indicator for the evaluation of surveillance and vaccination programmes, disease eradication planning and to monitor the distribution of seropositive cases of melioidosis in Malaysia.

Melioidosis usually results in chronic debilities that reduce the
productivity of animals and condemnation of carcasses in abattoir. Melioidosis is reemerging among animals and humans, and anecdotal reports suggest an increase in disease observation. This study described the seroprevalence of melioidosis in livestock based on the data obtained from the Department of Veterinary Services, Putrajaya and the Veterinary Research Institute, Ipoh. The data were summarized according to animal species, state, and year. The seroprevalence rate in animals was 7.6, 48.2, 2.6, 13.6 and 3.6% in cattle, buffaloes, goats, sheep and pigs respectively. The
seroprevalence of the disease varies in different states of the federation. For all species, the seroprevalence vary between
2.6% and 48.2%. The seroprevalence over the years increased from 4.2% in 2000 to 12.0% in 2003 after which it varies between
the period 2004- 2007 and apparently declined between 2007 and 2009.